SARS CoV-2 IgG Spike S1 (CoV-2 IgG S1) Antibody |
|
abx137719-100tests |
Abbexa |
100 tests |
EUR 1237.5 |
Human IgG antibody Laboratories manufactures the sars-cov-1 antibody studies reagents distributed by Genprice. The Sars-Cov-1 Antibody Studies reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Sars-Cov-1 products are available in stock. Specificity: Sars-Cov-1 Category: Antibody Group: Studies
Human SARS-CoV-2 Nucleocapsid IgG (SARS-CoV-2 N IgG) ELISA Kit |
|
Abbexa |
100 µl |
EUR 687.5 |
GENLISA Human SARS-CoV IgG ELISA |
|
Krishgen |
1 x 96 wells |
EUR 302.5 |
CoV-2 IgG ELISA |
|
BioServUK |
96 tests |
EUR 758 |
|
Description: IgG Screening ELISA |
CoV-2 IgG+ ELISA |
|
BioServUK |
24 x 4 tests |
EUR 948 |
|
Description: IgG+ Confirmatory ELISA |
CoV-2 IgG S1 |
|
ProSpec Tany |
50µg |
EUR 900 |
|
Description: Recombinant Anti Human SARS CoV-2 IgG Spike S1 |
Studies information
SARS-CoV/SARS-CoV-2 Spike antibody, Chimeric MAb |
|
MBS8110617-002mL |
MyBiosource |
0.02mL |
EUR 210 |
SARS-CoV/SARS-CoV-2 Spike antibody, Chimeric MAb |
|
MBS8110617-01mL |
MyBiosource |
0.1mL |
EUR 480 |
SARS-CoV/SARS-CoV-2 Spike antibody, Chimeric MAb |
|
MBS8110617-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2010 |
SARS-CoV/SARS-CoV-2 Spike antibody,Chimeric MAb |
|
MBS8119476-002mL |
MyBiosource |
0.02mL |
EUR 210 |
SARS-CoV/SARS-CoV-2 Spike antibody,Chimeric MAb |
|
MBS8119476-01mL |
MyBiosource |
0.1mL |
EUR 480 |
SARS-CoV/SARS-CoV-2 Spike antibody,Chimeric MAb |
|
MBS8119476-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2010 |
SARS-CoV/SARS-CoV-2 Spike antibody,Chimeric MAb |
|
MBS8119477-002mL |
MyBiosource |
0.02mL |
EUR 210 |
SARS-CoV/SARS-CoV-2 Spike antibody,Chimeric MAb |
|
MBS8119477-01mL |
MyBiosource |
0.1mL |
EUR 480 |
SARS-CoV/SARS-CoV-2 Spike antibody,Chimeric MAb |
|
MBS8119477-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2010 |
SARS-CoV/SARS-CoV-2 Spike Antibody,Chimeric MAb |
|
MBS8119480-002mL |
MyBiosource |
0.02mL |
EUR 210 |
SARS-CoV/SARS-CoV-2 Spike Antibody,Chimeric MAb |
|
MBS8119480-01mL |
MyBiosource |
0.1mL |
EUR 480 |
SARS-CoV/SARS-CoV-2 Spike Antibody,Chimeric MAb |
|
MBS8119480-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2010 |
SARS-CoV/SARS-CoV-2 Spike Antibody, Chimeric MAb |
|
MBS8574846-01mg |
MyBiosource |
0.1mg |
EUR 705 |
SARS-CoV/SARS-CoV-2 Spike Antibody, Chimeric MAb |
|
MBS8574846-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2910 |
SARS-CoV/SARS-CoV-2 Spike antibody, Chimeric MAb |
|
MBS8574847-01mg |
MyBiosource |
0.1mg |
EUR 705 |
SARS-CoV/SARS-CoV-2 Spike antibody, Chimeric MAb |
|
MBS8574847-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2910 |
SARS-CoV-2 (COVID-19) NSP7 Antibody |
|
9155-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
|
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers. |
